×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Idea: APP Gene Dosage Reduction Therapy for Down Syndrome
idea
1,008 words
KG: APP
2026-03-29
kind:idea
kind:therapy-idea
section:ideas
state:published
topic:down-syndrome
topic:alzheimers
Contents
APP Gene Dosage Reduction Therapy for Down Syndrome
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70
Selective Cholinergic Protection via APP Pathway Modulation
Score: 0.43
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
PARP1 Inhibition Therapy
Score: 0.58
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Circadian Clock-Autophagy Synchronization
Score: 0.55
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Temporal Decoupling via Circadian Clock Reset
Score: 0.52
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50
Ganglioside Rebalancing Therapy
Score: 0.50
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Complement C1q Mimetic Decoy Therapy
Score: 0.48
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Arginine Methylation Enhancement Therapy
Score: 0.46
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44
Mitochondrial Transfer Pathway Enhancement
Score: 0.44
Show 25 more
Related Analyses (30)
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · completed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · completed
Epigenetic reprogramming in aging neurons
neurodegeneration · completed
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · completed
Show 25 more
Related Experiments (29)
Plasma ATN biomarkers across AD continuum in Chilean cohort
clinical · proposed · Score: 0.95
Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90
Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90
Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's diseas
validation · proposed · Score: 0.95
Anti-ASC antibody intracerebroventricular injection in APP/P
validation · proposed · Score: 0.95
Comparison of free-text clinical reports vs Mini-ICF-APP str
clinical · proposed · Score: 0.90
Diosmin cognitive rescue in APP/PS1 mice
validation · proposed · Score: 0.90
Behavioral assessment of APP/PSEN1/GD3S triple-mutant mice
validation · proposed · Score: 0.90
Immunofluorescence analysis of cerebral microvascular densit
exploratory · proposed · Score: 0.90
Transcriptomic profiling and differential expression analysi
exploratory · proposed · Score: 0.90
AhR agonist effects on NEP in APP/PS1 mice
validation · proposed · Score: 0.90
Amyloid plaque load analysis in triple-mutant mouse brains
exploratory · proposed · Score: 0.88
qPCR and western blot analysis of microvascular functional m
exploratory · proposed · Score: 0.85
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46
s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.46
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.46
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46
Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.46
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Cytochrome Therapeutics
clinical · proposed · Score: 0.46
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.46
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.46
Prion Strain Diversity and Selective Vulnerability
clinical · proposed · Score: 0.46
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.46
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.46
GPR109A receptor validation using knockout macrophages
exploratory · proposed · Score: 0.92
MAPK pathway inhibition by QTJD through butyrate mechanism
exploratory · proposed · Score: 0.90
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46
Show 24 more
See Also (9)
Accelerating Medicines Partnership for Alzheimer's Dise
institution · KG edge: implicated_in
ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Memb
gene · KG edge: inhibits
ACE Gene
gene · KG edge: associated_with
ABI3 Gene
gene · KG edge: associated_with
ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: activates
ABCA2 Gene - ATP Binding Cassette Subfamily A Member 2
gene · KG edge: degrades
ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates
A2M Gene
gene · KG edge: interacts_with
ABCA7 (Redirect)
redirect · KG edge: interacts_with
Show 4 more
Knowledge Graph (12 edges)
APP
causes
EOAD
APP
causes
FAMILIAL_AD
APP
interacts_with
EIF2AK2
APP
regulates
ST6GAL1
APP
regulates
MAX
APP
therapeutic_target
EGFR
APP
therapeutic_target
BACE1
APP
regulates
FUT8
APP
associated_with
MTOR
APP
associated_with
PIK3C3